| X24-06-ZQ462 |
Bcr-Abl inhibitor GNF 7, Purity ≥98%
|
|
| X24-06-ZQ466 |
Bcr-Abl inhibitor GZD824, Purity ≥98%
|
|
| X24-06-ZQ467 |
Bcr-Abl inhibitor GZD824 dimesylate, Purity ≥98%
|
|
| X24-06-ZQ483 |
Bcr-Abl inhibitor AMN-107, Purity ≥98%
|
|
| X24-06-ZQ484 |
Bcr-Abl inhibitor Nilotinib monohydrochloride monohydrate, Purity ≥98%
|
|
| X24-06-ZQ486 |
Bcr-Abl inhibitor NRC-AN-019, Purity ≥98%
|
|
| X24-06-ZQ497 |
Bcr-Abl inhibitor PD173955, Purity ≥98%
|
|
| X24-06-ZQ522 |
Bcr-Abl inhibitor Radotinib, Purity ≥98%
|
|
| X24-06-ZQ527 |
Bcr-Abl inhibitor SNIPER(ABL)-062, Purity ≥98%
|
|
| X24-06-ZQ536 |
Bcr-Abl inhibitor Vodobatinib, Purity ≥98%
|
|
| X24-06-ZQ537 |
Bcr-Abl inhibitor WP1130, Purity ≥98%
|
|
